WallStreetZenWallStreetZen

NASDAQ: ALLO
Allogene Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Allogene Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ALLO annual revenue was $0.0, with -100% growth year-over-year.

ALLO past revenue growth

How has ALLO's revenue growth performed historically?

Company
-100%
Industry
379.98%
Market
88.6%
ALLO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALLO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ALLO revenue history

Current Revenue
$0.0
Current Earnings
-$190.9M
Current Profit Margin
0%

Be the first to know when ALLO announces revenue.

ALLO Revenue History By Year

ALLO Yearly RevenueALLO RevenueALLO ChangeALLO Revenue Growth
2025-12-31$0.00-$22.00k-100.00%
2024-12-31$22.00k-$73.00k-76.84%
2023-12-31$95.00k-$61.00k-39.10%
2022-12-31$156.00k-$113.93M-99.86%
2021-12-31$114.09MN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Allogene Therapeutics Revenue FAQ

What was ALLO's revenue last quarter?

On Invalid Date, Allogene Therapeutics (NASDAQ: ALLO) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Allogene Therapeutics's revenue was $0.00.

What was Allogene Therapeutics's revenue in 2025?

Allogene Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a 100% decrease year over year.

How much does Allogene Therapeutics make in a day?

Based on Allogene Therapeutics annual revenue for the past five years, ALLO makes an average of $62,664.11 per day.

What was Allogene Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Allogene Therapeutics's revenue has grown -100% year over year. This is 479.98 percentage points lower than the US Biotechnology industry revenue growth rate of 379.98%. Allogene Therapeutics's revenue in the past year totaled $0.00.

How much does Allogene Therapeutics make in a year?

Allogene Therapeutics's revenue by year for the past five years is:
  • Allogene Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a 100% decrease year over year.
  • Allogene Therapeutics's annual revenue for Dec 31, 2024 was $22.00 thousand, a 76.84% decrease from 2023.
  • Allogene Therapeutics's annual revenue for 2023 was $95.00 thousand, a 39.1% decrease from 2022.
  • Allogene Therapeutics's annual revenue for 2022 was $156.00 thousand, a 99.86% decrease from 2021.
  • Allogene Therapeutics's annual revenue for 2021 was $114.09 million, a Infinity% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.